Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: THE JOHNS HOPKINS UNIVERSITY
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-17 to 2022-03-31
Current total value of award: $116384
Description: LONG-TERM FOLLOW UP OF SUBJECTS PREVIOUSLY ENROLLED IN A PHASE I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND IMMUNOGENICITY OF RECOMBINANT LIVE ATTENUATED TETRAVALENT DENGUE VIRUS VACCINE ADMIXTURES IN HEALTHY ADULTS